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Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the US. CRC survivors may
have complex healthcare needs requiring care from both specialists and primary care. Our objective was to
understand how CRC survivors perceive their survivorship care, especially management of their cardiovascular-
related chronic diseases.
Methods: We identified patients diagnosed with non-metastatic CRC between 10/1/2007 and 12/31/2015 at Veterans
Affairs Medical Centers in North Carolina or Virginia. In 2016, we conducted telephone-based, semi-structured interviews
to assess survivors’ experiences with cancer survivorship and changes in health priorities. Interviews were conducted
until thematic saturation was reached. Interviews were audio-recorded, transcribed, and coded.
Results: The 25 participants were, on average, 64 years old and approximately 4 years post-CRC diagnosis at the time of
interview; most were white (60%), male (92%), and diagnosed with colon cancer (64%) as opposed to rectal cancer. CRC
survivors reported: (1) a shift in focus from surviving cancer to reducing cardiovascular disease risk (e.g., by managing
weight); (2) challenges with taking medications for CVD-related conditions; (3) new recognition of the importance of
engaging with primary care providers.
Conclusions: Experiences with cancer shapes how survivors view their health. Management of cardiovascular-related
chronic disease is important to veteran CRC survivors. There is a need to deliver cardiovascular disease risk reduction
programs tailored for CRC survivors.
Keywords: Veteran health, Colorectal cancer, Cancer survivorship, Qualitative research, Chronic disease, Cardiovascular
disease, Medication adherence
Background
The Veterans Affairs (VA) healthcare system is the
largest integrated healthcare systems in the US and a
high-volume provider of cancer care in the US [1].
Among VA patients and across the US, colorectal cancer
(CRC) is the third most commonly-diagnosed cancer [1, 2].
Due to robust national programs, approximately 80% of VA
patients undergo CRC screening [3, 4]. With earlier detec-
tion and advances in cancer treatment, CRC-related death
rates for older adults (aged ≥ 50 years) are declining.
Currently there are approximately 1 million U.S. CRC
survivors [5, 6].
Among cancer survivors, approximately half of non-
cancer deaths are attributed to cardiovascular disease
(CVD) [7, 8]. Compared to people without a history of
CRC, CRC survivors may have moderately increased risk
of CVD for several reasons. First, CRC and CVD have
similar risk factors (e.g., sedentary behaviors, poor quality
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diet, short sleep, tobacco use; Table 1; Additional file 1:
Figure S1) [9–12]. Secondly, adjuvant treatment for CRC
increases the likelihood of developing hypertension, which
is a leading CVD risk factor [13]. Finally, for some CRC
survivors, the side effects of CRC treatment (e.g., periph-
eral neuropathy and having an ostomy) [14–16] may make
it more difficult to maintain appropriate levels of physical
activity [14, 15].
The VA has a rich history of developing chronic
disease prevention and CVD risk management pro-
grams. These programs provide an integrated ap-
proach to controlling chronic diseases through patient
education, monitoring, and coordinating services. The
high quality of CRC care provided in the VA is well-
reputed [17–22]. Yet, relatively little effort has been
made to implement chronic disease management
specifically in the context of VA cancer survivorship.
Similarly, there has been little research addressing
CRC survivors’ perceived follow-up care related to CVD
risk management [23–25]. Our objective was to under-
stand CRC survivors’ perspectives on cancer survivorship
experiences and chronic disease management in VA
Medical Centers (VAMCs). We were particularly in-
terested in describing how VA CRC survivors’ health
priorities change as they complete active treatment
and focus on cancer surveillance and survivorship
care. Understanding CRC survivors’ perceptions is an
important foundation to develop patient-centered
chronic disease management programs tailored to
meet the needs of CRC survivors.
Methods
We identified potential participants from the VA Cancer
Cube maintained by the Veterans Health Affairs Support
Service Center. The VA Cancer Cube uses the national
cancer case ascertainment system, based on histology
and first course of treatment, to identify patients with
suspected cancers [26].
To be eligible for this study, participants must have
been diagnosed with incident Stage I, II, or III cancer of
the colon or rectum between October 1, 2007 and
December 31, 2015 at VAMCs in North Carolina or
Virginia and have a valid home mailing address. We
interviewed CRC survivors approximately 1 to 9 years
post-CRC diagnosis, a timeframe consistent with previ-
ous work [27]. To confirm that patients met the eligibil-
ity criteria, we reviewed the electronic health record.
Potential participants were mailed a letter explaining the
study, a prepaid mailing envelope, and a self-administered
survey assessing demographics, symptoms, barriers to
care, and adherence with recommended care (e.g., CRC
surveillance, medications). On the cover page of the
survey, patients indicated whether they agreed to be con-
tacted for a future telephone-based interview. These inter-
views were the primary data source for this analysis. The
VA CRC population and our study sample are primarily
comprised of men [1]. To ensure representation of
females and minorities, we interviewed all women who
provided consent and prioritized interviewing racial mi-
nority patients. We then selected participants to ensure
equal representation by stage of disease (e.g., I, II, or III)
and cancer type. Because their treatment patterns are dif-
ferent (i.e., rectal patients may receive radiation therapy,
whereas colon cancer patients generally do not) which af-
fects their side effects, we oversampled rectal cancer
patients.
Semi-structured, telephone-based interviews were con-
ducted between May 5, 2016 and August 8, 2016 by two
health services researchers trained in behavioral sciences
and qualitative interview techniques (SMA and LLZ).
Our interview guide incorporated feedback obtained
through meetings with primary care professionals, gas-
troenterologists, social psychologists, and qualitative
health services researchers located at the Durham
VAMC and Duke University. The questions addressed
prioritization of health needs, among other issues. The
interview guide questions are summarized in the
Additional file 2. In this analysis, we report on survivors’
experiences with cancer survivorship, survivors’ discussion
about their prioritization of health needs, and how these
have changed since their CRC diagnosis and treatment.
To characterize the sample, we obtained demographic
and clinical characteristics from the VA electronic health
record. Interviews were audio-recorded using Sparky USB
devices and later transcribed (Weston, CT). Qualitative
Table 1 Factors influencing CRC and CVD
Risk Factors CRC CVD
Cigarette smoking ✓ ✓
Poor quality diet ✓ ✓
Physical inactivity ✓ ✓
Short sleep ✓ ✓
Diabetes diagnosis ✓ ✓
Obesity ✓ ✓
Heavy alcohol use ✓ ✓
Hereditary conditions (e.g., familial
adenomatous polyposis, Lynch Syndrome)
✓
Elevated lipids/ cholesterol ✓
Family history of CVD ✓
Protective Factors
Primary care use ✓ ✓
Statin use ✓ ✓
Aspirin use ✓ ✓
Physical activity ✓ ✓
Healthy diet ✓ ✓
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software, ATLAS.ti v6.2 (Berlin, Germany), was used to
manage data. We used conventional content analysis to
describe the phenomenon of health priority perspective of
VA CRC survivors [28]. Codes were derived from review
of the interview transcript text rather than being estab-
lished a priori. Four members of the research team (SMA,
LLZ, KMG, and CIV) met to review the first four tran-
scripts to identify an initial set of emergent codes. Once
codes had been identified, subsequent interviews were
independently coded by two members of the research
team (LLZ and KMG). Team members met to discuss
questions about coding and reach consensus. The team
members then aggregated codes into content categories.
Analysts worked together to synthesize results into key
themes. This study was approved by the Durham VA
Health Care System Institutional Review Board.
Results
Participant characteristics
Of the 129 survivors who completed the survey, 66
agreed to be contacted for a qualitative interview. We
contacted 33 potential participants, of whom 25 com-
pleted the individual interviews (Fig. 1). On average,
participants were 64 years old; most were white, mar-
ried or partnered, males diagnosed with colon (as
opposed to rectal) cancer (Table 2). Participants were
an average of approximately 4 years post-CRC diagnosis
at the time of their interview. Interviews lasted an aver-
age of 26 min.
Shifting focus from surviving cancer to reducing CVD
CRC survivors reported that their focus has shifted from
surviving cancer to managing chronic conditions. Some
survivors reported that their most significant health pri-
ority was now heart health. A man with stage 1 colon
cancer reported: “My biggest problem is my heart… I
figure if I take care of my heart, I will be around a whole
lot longer” and “I was careful for about a year. Then it
just went all to pieces. When I started back at the VA, I
had talks with the doctors...Then I started changing my
living habits drastically.” Survivors also described a
newly found interest in receiving preventive health
services, such as annual influenza vaccinations, after
their experience with CRC.
Survivors described comorbid conditions that were
diagnosed both before and after their CRC treatment;
most commonly, CVD-related chronic conditions and
arthritis which are responsive to lifestyle behavior
change. A man with stage 2 rectal cancer said: “I had
Hepatitis C before I found out I had cancer. And then
the diabetes happened after the cancer… But I’m mostly
Fig. 1 Patient flow
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controlling it with my diet and then I was trying to walk
a mile a day.”
Weight management concerns were commonly-
expressed by participants as a mechanism to reduce
their CVD risk. Some survivors reported low levels of
physical activity and poor diet both before and after their
cancer diagnosis and treatment, which caused them to
gain weight. Conversely, some survivors reported weight
loss associated with CRC, which resulted in easier con-
trol of their chronic conditions. As an example, a man
with stage 1 colon cancer said: “I’m no longer on insu-
lin… I’m barely a borderline diabetic right now. A lot of
that was weight loss. Before I started treatments and
everything, I weighed in at 235 pounds. And now I’m
keeping my weight down to 180, 185 somewhere around
there.” Survivors also discussed how the cancer
experience has shaped their understanding of the im-
portance of weight management. A man with stage 2
colon cancer said: “I’ve always been more on the plumper
side than the thinner side… As a result, I’m becoming
more proactive, and that I would say was probably some-
what because of [finishing] my [cancer] treatments.
Things that have taken place that have made me more
aware of how I can benefit myself by being more astute
about what I do”.
Challenges with taking medications for CVD-related
conditions
CRC survivors reported that their perspectives on medi-
cation use had changed over the course of their cancer
journey. Survivors now reported taking medications as
prescribed to be important to them, whereas before their
CRC experience it seemed more of a nuisance. A man
with stage 3 colon cancer said: “[Now I’m] takin’ the
medications I’m supposed to…Nothing to do with the
cancer. Just the heart stuff.” Similarly, a second man with
stage 1 colon cancer reported: “I used to have medica-
tions and I wouldn’t take [them] like I was supposed to,
but now I make sure that that I do.”
Survivors also reported that their medication needs
have changed after cancer treatment. A man with stage
3 colon cancer and comorbid diabetes stated: “I take
insulin every night… [When] you take chemo, you know,
[your blood sugar] automatically shoots up 200 … [After
the] treatment, my sugar levels are different now… I was
just taking pills for my sugar diabetes, now I’m taking 30
units of insulin every night. I hope that [it doesn’t get]
worse… It’s all different…”.
Despite the uniqueness of the cancer experience in
motivating better medication adherence, CRC survivors
reported barriers that are similar to the general popula-
tion. [29, 30] These included problems with polypharmacy
(e.g., taking multiple medications daily), scheduling (e.g.,
difficulty taking medications at specific times of day), for-
getfulness, lacking support, being worried about taking
them for the duration of life, struggling with depression,
and running out of a prescription too soon. A man with
stage 2 colon cancer described his medication behaviors
this way: “I just know that I take all my medicines, on time,
every day. My wife sees to that because of this memory loss
I have….”
New recognition of the important of engaging with
primary care providers
CRC survivors reported working with their VA pri-
mary care provider for chronic disease management,
including medications. When connected with primary
care, survivors noted that their primary care provider
was charting the course for post-cancer care and pro-
viding traditional chronic disease management. A
man with stage 3 colon cancer reported: “I visited
with [my primary care provider] several times and she
laid out my plan… I have high blood pressure and I
take medication for that. [She] makes sure I’m follow-
ing up and checking my blood pressure and [that I]
have my prescription pills... Those are things my VA
Table 2 Characteristics of interview participants (n = 25)
Percent/ Mean SD (Min, Max)
Age, years 64 6.93 (50, 80)
Sex
Male 92% –
Female 8% –
Race
White race 60% –
Black race 28% –
Other race 12% –
Marital status
Married or living with partner 52% –
Divorced or separated 32% –
Widowed 4% –
Single, never married 12%
Stage at Diagnosis
Stage 1 32% –
Stage 2 28% –
Stage 3 40% –
Cancer Type
Colon 64% –
Rectum 28% –
Rectosigmoid junction 8%
Note: These data were derived from patients’ electronic health record
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primary care doctor does for me. When I need a refill
it’s just a matter of dialing a number and refilling my
prescription no question about it.”
Findings consistent with existing literature
The CRC survivors in our cohort confirmed experiences
reported in other literature, thus we did not elevate
these finding to the level of an emerging theme [31, 32].
In addition to the key themes that we identified, survi-
vors also reported changes in their daily routines. A man
with stage 2 rectal cancer stated: “You learn to keep up
with your bowel movements… You know some days you
can get by with doing more than you can on other days
[and] plan things accordingly.” Despite these changes,
survivors expressed resiliency and emphasized the im-
portance of self-care in returning to a “new normal.”
While this idea of changing daily routines and a “new
normal” are important, it has been well described in
existing literature and thus we did not identify it as an
emerging theme in this analysis [33, 34].
Cancer survivors may have more complex care coord-
ination needs that are time-dependent. During survivor-
ship care, coordination of health care services may
become a priority. They also reported care coordination
advantages of receiving all their care within an inte-
grated healthcare system. A man with stage 3 colon
cancer reported: “My doctors there at [the VA] are an
outstanding crew… If I run into any medical problems I
try to maintain the same doctors who have a history of
my medical needs who can better assist me to live on a
day to day basis...” Similarly, another man with stage 3
colon cancer said: “They all communicated very well
between each other because of the [integrated electronic
health] record. I’d go see my primary care doctor and
he’d have all my results from the CAT scans, all my
blood work information, he always had everything right
at his fingertips. They all did.”
Discussion
We sought to understand how CRC survivors perceive
their survivorship care related to CVD. We identified
several new themes (e.g., shifted from surviving cancer
to managing chronic conditions, challenges with taking
chronic medications; recognition of the importance of
engaging primary care providers) as well as several
themes consistent with the general patient population
and other cancer survivors cohorts (e.g., changes in daily
routine, issues with care coordination) [14, 15, 20, 35–37].
In addition, CRC survivors reported CRC treatment side
effects, such as peripheral neuropathy and changes in
bowel habits, that would require adapting CVD risk redu-
cing interventions due to a need to modify behavioral life-
style recommendations.
Maintaining physical activity and weight management
Physical activity is associated with improved survival
among CRC survivors. For example, engaging in leisure-
time physical activity is associated with lower all-cause
mortality [9]. Thus, engaging in physical activity is im-
portant. Clinicians could ask CRC survivors about symp-
toms impacting their willingness to engage in physical
activity, and create alternative suggestions for ways to
remain active (e.g., walking on smooth surfaces, taking
an extra lap around the grocery store to add activity into
daily routines).
Physical inactivity is associated with weight manage-
ment problems and CRC survivors who are overweight
are more likely to suffer from comorbid CVD [38]. CRC
survivors in our cohort reported weight loss coinciding
with their CRC diagnosis, which is associated with worse
outcomes and increased mortality [39]. This is part of
the “obesity paradox” and appropriate weight manage-
ment among cancer survivors is remains important [40].
CRC survivors reported that their bowel habits changed,
prompting them to change their dietary patterns. Clini-
cians should address weight management with their CRC
survivors, asking whether side effects of treatment are
making weight management challenging.
Taking medications as prescribed
Survivors reported barriers similar to those reported by
patients with chronic conditions (e.g., forgetting to take
their medications, not getting them refilled in time) [30].
Evidence suggests that nonadherence may be more
common among cancer survivors than the general popu-
lation and that nonadherence may vary based on cancer
treatment and other characteristics. A recent study
evaluated adherence to cardiovascular related medica-
tions (e.g., statins and ACEIs/ARBs/β-blockers) in the
12 months before and 12 months after cancer diagnosis
among elderly Medicare beneficiaries with colorectal,
prostate, and breast cancers [41]. The authors found that
adherence to both statins and ACEIs/ARBs/β-blockers
was only about 31% during the 4 months following
patients’ cancer diagnosis. An important minority, ap-
proximately 14% of patients, were not adherent to both
medication classes (e.g., statins and ACEIs/ARBs/β-
blockers) [41]. Even in an integrated healthcare system,
adherence is problematic for cancer survivors. Another
study conducted among early stage breast cancer survi-
vors receiving care in an integrated healthcare system
found that 75% of patients were nonadherent [42].
Whether these challenges translate into different medi-
cation adherence behaviors has not been well studied.
Thus, medication adherence for chronic disease medica-
tions may be particularly important and life-prolonging
for CRC survivors.
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Medical oncologists and primary care providers have
different perceptions regarding cancer survivorship activ-
ities [43] and differing perspectives on models of cancer
survivorship care [44]. Primary care may be particularly
important partner to reduce CVD risk among CRC survi-
vors. CRC survivors report holding the advice of their pro-
viders in high esteem [45] and primary care use is
associated with lower CRC incidence and reduced all-
cause mortality [46].
Study limitations
Our analysis involves CRC survivors receiving VA health-
care in the southeastern United States. In an effort to in-
clude a wide array of perspectives, we interviewed survivors
with both colon and rectal cancer and who were 1 to 9 years
post-diagnosis; thus, our findings may not be generalizable
to experiences among survivors who were closer or farther
from their time of diagnosis. Our findings regarding chal-
lenges with taking medications do not consider how many
medications participants were prescribed. While the quali-
tative interview approach allows for better understanding
of the patient perspective and provides rich information, it
does not elucidate survivors’ behaviors with objective data
(e.g., medication adherence, physical activity). Other study
designs, such as prospective observational studies, may be
employed to characterize CVD-related health behaviors
among CRC survivors.
Conclusions
It is important to note that many of the survivors in our
study identified a specific CVD risk-reducing behavior
(e.g., weight management, engaging in physical activity)
that was of increased importance to them after their
cancer experience. However, evidence suggests that im-
provements in mortality and recurrence risk may not be
attributed to a single behavior but instead to a holistic
healthy lifestyle [47]. There is a need to deliver CVD risk
management programs that address multiple risk reduc-
tion strategies (e.g., diet, exercise, sleep, medication ad-
herence) and which are tailored for CRC survivors. CVD
risk management programs for cancer survivors should
acknowledge the cancer experience, make recommenda-
tions tailored for survivors’ abilities (e.g., physical activity
recommendations adapted for survivors with peripheral
neuropathy; diet recommendations adapted for survivors
managing changed bowel movement frequency; fatigue),
and include education about cancer surveillance. These
programs should educate patients jointly on the import-
ance of engaging in healthy behaviors to reduce their
likelihood of CRC recurrence, reduce their CVD risk,
and improve their quality of life. Primary care providers,
in conjunction with their oncology colleagues, may be
uniquely positioned to support this effort.
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